Arrowhead officer proposes $750K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arrowhead Pharmaceuticals (ARWR) officer James Hamilton reported a proposed sale of 10,000 common shares, with an aggregate market value of $749,997.60 and an approximate sale date of April 23, 2026. Merrill Lynch is named as the broker. Hamilton's reported sales during the past three months included 10,000 common shares sold March 5, 2026, for gross proceeds of $641,870.05.
Key Figures
Key Terms
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.